U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Showing 1 - 4 of 4 results

HAEMOPHILUS INFLUENZAE TYPE B STRAIN 20752 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN

MORE DETAILS

C9R35M8XV6

structurally diverse
Status:
Possibly Marketed Outside US
First approved in 2009
Class:
STRUCTURALLY DIVERSE

HAEMOPHILUS INFLUENZAE TYPE B STRAIN 1482 CAPSULAR POLYSACCHARIDE TETANUS TOXOID CONJUGATE ANTIGEN

MORE DETAILS

FLV5I5W26R

structurally diverse
Status:
US Approved Rx (2000)
First approved in 1993
Class:
STRUCTURALLY DIVERSE

HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN

MORE DETAILS

LUY6P8763W

Concept
Status:
US Approved Rx (1989)
First approved in 1989
Class:
CONCEPT

HAEMOPHILUS B CONJUGATE VACCINE (MENINGOCOCCAL PROTEIN CONJUGATE)

MORE DETAILS

LUY6P8763W

Concept
Status:
Other
Class:
CONCEPT
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966